Pirtobrutinib results in reversible platelet dysfunction compared to ibrutinib and acalabrutinib.

Bye AP., Kriek N., Sage T., Rawlings SJ., Prodger C., Kesavan M., Lees C., Booth S., Cowen LG., Shefferd K., Desborough MJ., Gibbins JM., Eyre TA.

DOI

10.3324/haematol.2022.281402

Type

Journal article

Publication Date

2023-05-01T00:00:00+00:00

Volume

108

Pages

1429 - 1435

Total pages

6

Keywords

Humans, Pyrazines, Benzamides, Protein Kinase Inhibitors, Leukemia, Lymphocytic, Chronic, B-Cell, Adenine, Piperidines, Pyrazoles

Permalink More information Close